Literature DB >> 16932299

Mechanisms of disease: the adrenocorticotropin receptor and disease.

Adrian J L Clark1, Louise A Metherell.   

Abstract

The action of the peptide hormone adrenocorticotropin (ACTH) to stimulate glucocorticoid production by the adrenal gland is an essential physiologic process, yet is dependent on a single unique genetic component--the ACTH receptor or melanocortin 2 receptor. Genetic defects that cause abnormalities in this receptor or in a protein required for its expression at the cell surface result in a potentially fatal disease (familial glucocorticoid deficiency). Overexpression of this receptor or inability to desensitize it is found in adrenal adenomas or hyperplasia associated with glucocorticoid overproduction (Cushing syndrome). These disorders are uncommon, but there are considerable data to show that the hypothalamo-pituitary-adrenal axis is overactive, or in some circumstances underactive, in more common situations including depressive illness and septic shock. The origin of these latter disturbances is undoubtedly complex and multifactorial, but there is good evidence that a component of this phenomenon is an altered responsiveness of the ACTH receptor to ACTH. Understanding the basis of ACTH responsiveness might, therefore, contribute to the understanding of disorders such as these and perhaps enable the hypothalamo-pituitary-adrenal axis to be manipulated beneficially in these circumstances.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932299     DOI: 10.1038/ncpendmet0165

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN: 1745-8366


  7 in total

1.  ACTH and cortisol responses to ghrelin and desmopressin in patients with Cushing's disease and adrenal enlargement.

Authors:  D Miljic; M Joksimovic; M Doknic; M Ivovic; M Djurovic; S Pekic; M Tancic; I Soldatovic; M Stojanovic; Dj Nale; Dj Macut; S Damjanovic; V Popovic
Journal:  J Endocrinol Invest       Date:  2010-02-05       Impact factor: 4.256

2.  Molecular identification of the human melanocortin-2 receptor responsible for ligand binding and signaling.

Authors:  Min Chen; Charles J Aprahamian; Robert A Kesterson; Carroll M Harmon; Yingkui Yang
Journal:  Biochemistry       Date:  2007-09-18       Impact factor: 3.162

Review 3.  Structure and function of the melanocortin2 receptor accessory protein (MRAP).

Authors:  Patricia M Hinkle; Julien A Sebag
Journal:  Mol Cell Endocrinol       Date:  2008-11-06       Impact factor: 4.102

Review 4.  Androgen receptors beyond prostate cancer: an old marker as a new target.

Authors:  Javier Munoz; Jennifer J Wheler; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-01-20

5.  Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children.

Authors:  Li F Chan; Daniel C Campbell; Tatiana V Novoselova; Adrian J L Clark; Louise A Metherell
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-05       Impact factor: 5.555

Review 6.  Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome.

Authors:  Claudia Gragnoli
Journal:  Appl Clin Genet       Date:  2014-04-01

Review 7.  ACTH Antagonists.

Authors:  Adrian John Clark; Rachel Forfar; Mashal Hussain; Jeff Jerman; Ed McIver; Debra Taylor; Li Chan
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-05       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.